冯伟, 谢亚非, 华东东, 石慧, 刘磊. IRE1α抑制剂的研究进展J. 药学学报, 2023, 58(10): 2970-2978. DOI: 10.16438/j.0513-4870.2023-0042
引用本文: 冯伟, 谢亚非, 华东东, 石慧, 刘磊. IRE1α抑制剂的研究进展J. 药学学报, 2023, 58(10): 2970-2978. DOI: 10.16438/j.0513-4870.2023-0042
FENG Wei, XIE Ya-fei, HUA Dong-dong, SHI Hui, LIU Lei. Research progress of IRE1α inhibitorsJ. Acta Pharmaceutica Sinica, 2023, 58(10): 2970-2978. DOI: 10.16438/j.0513-4870.2023-0042
Citation: FENG Wei, XIE Ya-fei, HUA Dong-dong, SHI Hui, LIU Lei. Research progress of IRE1α inhibitorsJ. Acta Pharmaceutica Sinica, 2023, 58(10): 2970-2978. DOI: 10.16438/j.0513-4870.2023-0042

IRE1α抑制剂的研究进展

Research progress of IRE1α inhibitors

  • 摘要: 肌醇需求酶1α (inositol requiring enzyme 1 alpha, IRE1α) 是一种内质网应激(endoplasmic reticulum stress, ER stress) 感受器, 广泛表达于哺乳动物中。IRE1α通路在未折叠蛋白反应(unfoided protein response, UPR) 的3条信号通路中是最保守的。研究表明, IRE1α过表达与肿瘤的发生、发展有着密切的联系, 因此, IRE1α抑制剂的研究对新型抗肿瘤药物的发现有着重要的意义。本文综述了具有抗肿瘤活性的IRE1α抑制剂, 并从作用机制、结构特点、抑制活性等方面进行了总结, 希望为靶向IRE1α治疗肿瘤的研究提供思路。

     

    Abstract: Inositol requiring enzyme 1 alpha (IRE1α), a widespread transmembrane protein in mammals, is an endoplasmic reticulum stress (ER stress) receptor. Among the three signaling pathways of the unfolded protein response (UPR), the IRE1α pathway is the most conservative. And there is a growing body of evidence that the occurrence and development of tumors is closely related to the over-expression of IRE1α. Therefore, the study of the IRE1α inhibitors is of great significance to the discovery of new anti-tumor drugs and has been attracting more and more attention. In the hope of providing ideas for the research of targeting IRE1α for cancer therapy, this paper reviewed the data of representative IRE1α inhibitors, including inhibitory activity, the mechanism of action, structural characteristics, and so on.

     

/

返回文章
返回